Abstract

BackgroundThe use of individual patient data (IPD) in network meta-analyses (NMA) is rapidly growing. This study aimed to determine, through simulations, the impact of select factors on the validity and precision of NMA estimates when combining IPD and aggregate data (AgD) relative to using AgD only.MethodsThree analysis strategies were compared via simulations: 1) AgD NMA without adjustments (AgD-NMA); 2) AgD NMA with meta-regression (AgD-NMA-MR); and 3) IPD-AgD NMA with meta-regression (IPD-NMA). We compared 108 parameter permutations: number of network nodes (3, 5 or 10); proportion of treatment comparisons informed by IPD (low, medium or high); equal size trials (2-armed with 200 patients per arm) or larger IPD trials (500 patients per arm); sparse or well-populated networks; and type of effect-modification (none, constant across treatment comparisons, or exchangeable). Data were generated over 200 simulations for each combination of parameters, each using linear regression with Normal distributions. To assess model performance and estimate validity, the mean squared error (MSE) and bias of treatment-effect and covariate estimates were collected. Standard errors (SE) and percentiles were used to compare estimate precision.ResultsOverall, IPD-NMA performed best in terms of validity and precision. The median MSE was lower in the IPD-NMA in 88 of 108 scenarios (similar results otherwise). On average, the IPD-NMA median MSE was 0.54 times the median using AgD-NMA-MR. Similarly, the SEs of the IPD-NMA treatment-effect estimates were 1/5 the size of AgD-NMA-MR SEs. The magnitude of superior validity and precision of using IPD-NMA varied across scenarios and was associated with the amount of IPD. Using IPD in small or sparse networks consistently led to improved validity and precision; however, in large/dense networks IPD tended to have negligible impact if too few IPD were included. Similar results also apply to the meta-regression coefficient estimates.ConclusionsOur simulation study suggests that the use of IPD in NMA will considerably improve the validity and precision of estimates of treatment effect and regression coefficients in the most NMA IPD data-scenarios. However, IPD may not add meaningful validity and precision to NMAs of large and dense treatment networks when negligible IPD are used.

Highlights

  • The use of individual patient data (IPD) in network meta-analyses (NMA) is rapidly growing

  • With its increased use has come a number of methodological developments, including the expansion from aggregate data (AgD) to the combined use of individual patient data (IPD) and AgD [2]

  • The National Institute for Health Care and Excellence (NICE) guidance demonstrates that population-adjusted indirect comparisons (PAIC) can be used in connected networks to adjust for imbalances in effect-modifiers and in disconnected networks to adjust for both effect-modifiers and other prognostic factors

Read more

Summary

Introduction

The use of individual patient data (IPD) in network meta-analyses (NMA) is rapidly growing. With its increased use has come a number of methodological developments, including the expansion from aggregate data (AgD) to the combined use of individual patient data (IPD) and AgD [2]. Many of these newer methods have been highlighted in the recent, and highly influential, National Institute for Health Care and Excellence (NICE) Technical Support Document 18 [3]. A great achievement of PAIC has been its important uptake, both in the general research community [4] and within the health technology assessment (HTA) community [5] The latter has been important in the current pharmaceutical climate that often sees treatments fast-tracked through development due to very promising early results, which can lead to noncomparative studies. While the first phase of uptake of IPD use within HTA submissions has been principally focused on disconnected networks, a consistent criticism of such analyses has been the lack of prognostic factors being adjusted for [5]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call